Total Payments
$904.35
2023 Payments
$448.62
Companies
20
Transactions
50
Medicare Patients
486
Medicare Billing
$34,476
Payment Breakdown by Category
Food & Beverage$904.35 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $904.35 | 50 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $112.63 | 5 | $0 (2023) |
| PFIZER INC. | $103.13 | 6 | $0 (2023) |
| Novo Nordisk Inc | $98.56 | 7 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $91.04 | 4 | $0 (2023) |
| Amarin Pharma Inc. | $84.61 | 5 | $0 (2022) |
| Lilly USA, LLC | $71.41 | 5 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $50.42 | 2 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $48.35 | 3 | $0 (2023) |
| Corium, LLC | $43.33 | 2 | $0 (2023) |
| Biogen, Inc. | $24.25 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $448.62 | 22 | Novartis Pharmaceuticals Corporation ($112.63) |
| 2022 | $259.16 | 17 | Janssen Pharmaceuticals, Inc ($51.24) |
| 2021 | $196.57 | 11 | Amarin Pharma Inc. ($37.00) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/07/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Neuroscience | ||||||
| 08/31/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.31 | General |
| 08/10/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/04/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/02/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.67 | General |
| Category: PSYCHIATRY | ||||||
| 06/30/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/21/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $33.48 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/13/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Neuroscience | ||||||
| 06/05/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/01/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/19/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Diabetes | ||||||
| 04/18/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Oncology | ||||||
| 03/28/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Rare Disease | ||||||
| 03/22/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/13/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Obesity | ||||||
| 03/06/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 01/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Gastroenterology | ||||||
| 12/08/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/30/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Neuroscience | ||||||
| 10/26/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 161 | 200 | $47,940 | $11,045 |
| 2022 | 5 | 209 | 232 | $56,248 | $14,682 |
| 2021 | 4 | 92 | 134 | $29,132 | $8,143 |
| 2020 | 1 | 24 | 24 | $3,621 | $606.60 |
Total Patients
486
Total Services
590
Medicare Billing
$34,476
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 113 | $22,375 | $5,156 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 62 | $15,022 | $3,614 | 24.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 14 | $9,673 | $2,190 | 22.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $870.10 | $85.14 | 9.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 105 | $22,417 | $5,449 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 76 | $21,065 | $5,343 | 25.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 13 | $6,902 | $1,718 | 24.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $3,381 | $1,500 | 44.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 24 | 24 | $2,483 | $671.98 | 27.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 48 | $12,952 | $4,148 | 32.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 54 | $10,995 | $2,612 | 23.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 18 | $3,775 | $1,039 | 27.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 13 | 14 | $1,410 | $343.36 | 24.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 24 | $3,621 | $606.60 | 16.8% |
About Jeanette Smith
Jeanette Smith is a Family healthcare provider based in Gladwin, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2018. The National Provider Identifier (NPI) number assigned to this provider is 1952889016.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jeanette Smith has received a total of $904.35 in payments from pharmaceutical and medical device companies, with $448.62 received in 2023. These payments were reported across 50 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($904.35).
As a Medicare-enrolled provider, Smith has provided services to 486 Medicare beneficiaries, totaling 590 services with total Medicare billing of $34,476. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Gladwin, MI
- Active Since 08/01/2018
- Last Updated 07/12/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1952889016
Products in Payments
- SPRAVATO (Drug) $91.04
- Vascepa (Drug) $84.61
- ELIQUIS (Drug) $80.71
- LEQVIO (Drug) $73.27
- ZENPEP (Drug) $50.42
- XIFAXAN (Drug) $48.35
- Saxenda (Drug) $40.26
- ENTRESTO (Drug) $39.36
- Adlarity (Drug) $29.26
- MOUNJARO (Drug) $28.03
- Wegovy (Drug) $26.88
- TRULICITY (Drug) $26.66
- ADUHELM (Biological) $24.25
- REXULTI (Drug) $22.67
- QULIPTA (Drug) $22.59
- PREVNAR 13 (Biological) $22.42
- STRENSIQ (Biological) $22.42
- XYOSTED (Drug) $19.35
- KRYSTEXXA (Biological) $17.45
- EMGALITY (Drug) $16.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.